Novartis超10亿美元押注PROTAC---蛋白水解靶向嵌合体 诺华于本周四(4月11日)与Arvinas建立独家战略合作伙伴关系,推进前列腺癌的口服蛋白降解剂(PROteolysis TArgeting Chimera,PROTAC)。诺华公司将支付给Arvinas1.5亿美元的预付款,并承诺在开发、监管和...
The Frizzled-1/(beta(2))-adrenergic receptor chimera: pharmacological properties of a unique G protein-linked receptor. These data demonstrate that the Frizzled-1 chimera displays cardinal features of a G protein-coupled receptor, including agonist-induced sequestration, but ... AJ Decostanzo,XP Hu...